Cargando…
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies
Active targeting of nanoparticles to tumours can be achieved by conjugation with specific antibodies. Specific active targeting of the HER2 receptor is demonstrated in vitro and in vivo with a subcutaneous MCF-7 breast cancer mouse model with trastuzumab-functionalized gold nanoparticles. The number...
Autores principales: | Colombo, Miriam, Fiandra, Luisa, Alessio, Giulia, Mazzucchelli, Serena, Nebuloni, Manuela, De Palma, Clara, Kantner, Karsten, Pelaz, Beatriz, Rotem, Rany, Corsi, Fabio, Parak, Wolfgang J., Prosperi, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187442/ https://www.ncbi.nlm.nih.gov/pubmed/27991503 http://dx.doi.org/10.1038/ncomms13818 |
Ejemplares similares
-
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity
por: Mazzucchelli, Serena, et al.
Publicado: (2016) -
Comparison of the in Vitro Uptake and Toxicity of Collagen- and Synthetic Polymer-Coated Gold Nanoparticles
por: Marisca, Oana T., et al.
Publicado: (2015) -
Development of an Effective Tumor-Targeted Contrast
Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes
por: Tullio, Chiara, et al.
Publicado: (2021) -
Conjugation of Polymer-Coated Gold Nanoparticles with Antibodies—Synthesis and Characterization
por: Tan, Gamze, et al.
Publicado: (2015) -
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
por: Nold, Philipp, et al.
Publicado: (2017)